- Home
- VIVS vs GURE Comparison
VIVS vs GURE Comparison
Compare VIVS & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- GURE
- Stock Information
- Founded
- VIVS 2007
- GURE 2006
- Country
- VIVS United States
- GURE China
- Employees
- VIVS N/A
- GURE N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- GURE Major Chemicals
- Sector
- VIVS Health Care
- GURE Industrials
- Exchange
- VIVS Nasdaq
- GURE Nasdaq
- Market Cap
- VIVS 8.1M
- GURE 7.6M
- IPO Year
- VIVS N/A
- GURE 1992
- Fundamental
- Price
- VIVS $2.28
- GURE $5.22
- Analyst Decision
- VIVS
- GURE
- Analyst Count
- VIVS 0
- GURE 0
- Target Price
- VIVS N/A
- GURE N/A
- AVG Volume (30 Days)
- VIVS 104.1K
- GURE 93.2K
- Earning Date
- VIVS 11-12-2025
- GURE 11-18-2025
- Dividend Yield
- VIVS N/A
- GURE N/A
- EPS Growth
- VIVS N/A
- GURE N/A
- EPS
- VIVS N/A
- GURE N/A
- Revenue
- VIVS $142,000.00
- GURE $13,919,011.00
- Revenue This Year
- VIVS $42.38
- GURE N/A
- Revenue Next Year
- VIVS $15.42
- GURE N/A
- P/E Ratio
- VIVS N/A
- GURE N/A
- Revenue Growth
- VIVS 94.52
- GURE N/A
- 52 Week Low
- VIVS $1.41
- GURE $4.60
- 52 Week High
- VIVS $21.96
- GURE $14.70
- Technical
- Relative Strength Index (RSI)
- VIVS 38.84
- GURE 94.36
- Support Level
- VIVS $2.14
- GURE $0.46
- Resistance Level
- VIVS $2.44
- GURE $5.47
- Average True Range (ATR)
- VIVS 0.27
- GURE 0.15
- MACD
- VIVS -0.09
- GURE 0.47
- Stochastic Oscillator
- VIVS 10.00
- GURE 95.01
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.